- What is Aurum Ventures M.K.I's primary investment focus?
- Aurum Ventures M.K.I primarily focuses on providing financing and managerial resources to life science companies, with a geographical emphasis on Israeli and Israel-related opportunities. They invest in innovative therapeutics, devices, and pharmaceuticals, and occasionally consider non-therapeutics like agricultural biotechnology or bioenergy.
- Which sectors does Aurum Ventures M.K.I concentrate its investments in?
- Aurum Ventures M.K.I primarily concentrates its investments in Health Tech & Life Sciences, accounting for 14 of its portfolio companies. They also have investments in Media & Entertainment Technologies and Industrial Technologies.
- Can you name a recent notable exit for Aurum Ventures M.K.I?
- In August 2021, Aurum Ventures M.K.I saw an exit with Zebra Medical Vision, which was acquired by Nanox Vision for $200M.
- What was another significant exit for Aurum Ventures M.K.I in recent years?
- In June 2020, Aurum Ventures M.K.I had an exit with PolyPid, which went public on NASDAQ with a valuation of $272M, raising $69M.
- Who founded Aurum Ventures M.K.I?
- Aurum Ventures M.K.I was founded by Morris Kahn in 1998.
- What is the most recent investment stage Aurum Ventures M.K.I has participated in?
- According to startupim data, Aurum Ventures M.K.I has participated in a G Round investment in July 2022.
- What is Aurum Ventures M.K.I's approach to investment positions?
- Aurum Ventures M.K.I invests alone or together with other reliable partners, taking either a lead or follower position in its investments.
- Which portfolio company of Aurum Ventures M.K.I focuses on computational microscopy for blood diagnostics?
- Scopio Labs, a portfolio company of Aurum Ventures M.K.I, focuses on computational microscopy for blood diagnostics. They raised a D Round.
